煤粉再燃燃烧含氮组分转化机理的敏感性分析

本文以GRI 3.0数据库为基础,结合CHEMKIN模块软件中敏感性分析的方法对煤粉再燃燃烧过程进行了数值模拟研究.通过对整个全模型反应方程进行分析,可以把整个反应机理模型主要分为碳氢组分转化反应机理和含氮组分转化反应机理两大类.本文重点对含氮组分转化反应机理进行了分析.在模拟的基础上,对含氮组分HCN、HNCO、NHt、NCO等转化反应进行了分类,系统地讨论了燃烧过程中含氮组分转化反应对NO的敏感性分析,清晰地揭示了含氮组分生成与还原NO的途径以及作用大小,为实际超细煤粉再燃燃烧技术提供了一定的理论依据.     

中国隐性养老金债务精算模型及其应用研究

根据当前中国养老金发放的实际情况 ,利用生存年金理论 ,改进了国外传统生存年金系数模型 ,得到测算‘老人’养老金债务和‘中人’过渡性养老金债务的精算模型 .利用该模型 ,测算出 2 0 0 0年中国隐性养老金债务规模 ,并对影响养老金债务的因素进行敏感性分析 ,提出缩减隐性养老金债务规模的思路 .     

Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical,anticancer potential and other therapeutic applications

The Camellia sinensis plant provides a wide diversity of black, green, oolong, yellow, brick dark, and white tea. Tea is one of the majorly used beverages across the globe, succeeds only in the water for fitness and pleasure. Generally, green tea has been preferred more as compared to other teas due to its main constituent e.g. polyphenols which contribute to various health benefits. The aim of this updated and comprehensive review is to bring together the latest data on the phytochemistry and pharmacological properties of Camellia sinensis and to highlight the therapeutic prospects of the bioactive compounds in this plant so that the full medicinal potential of Camellia sinensis can be realised. A review of published studies on this topic was performed by searching PubMed/MedLine, Scopus, Google scholar, and Web of Science databases from 1999 to 2022. The results of the analysed studies showed that the main polyphenols of tea are the four prime flavonoids catechins: epigallocatechin gallate (EGCG), epicatechin gallate (ECG), epigallocatechin (EGC), and epicatechin (EC) along with the beneficial biological properties of tea for a broad heterogeneity of disorders, including anticancer, neuroprotective, antibacterial, antiviral, antifungal, antiobesity, antidiabetes and antiglaucoma activities. Poor absorption and low bioavailability of bioactive compounds from Camellia sinensis are limiting aspects of their therapeutic use. More human clinical studies and approaching the latest nanoformulation techniques in nanoparticles to transport the target phytochemical compounds to increase therapeutic efficacy are needed in the future.